Ambrobene Stoptussin, drops 10 ml

CoughDry, irritating, difficult to relieve cough of various etiologies; cough relief in the pre- and postoperative period.

Active ingredient

Butamirate, Guaifenesin

How to take, the dosage

The drug is taken after meals, the appropriate number of drops is dissolved in 100 ml of liquid (water, tea, fruit juice, etc.). If the drug is supplied with a syringe for dosing, you can use it for precise dosing.
Dose according to the body weight of the patient:

• under 7 kg at 8 drops 3-4 times a day,
• 7-12 kg at 9 drops 3-4 times a day,
• 12-20 kg at 14 drops 3 times a day,
• 20-30 kg at 14 drops 3-4 times a day,<
• 30-40 kg 16 drops 3-4 times a day,
• 40-50 kg 25 drops 3 times a day,
• 50-70 kg 30 drops 3 times a day,
• over 70 kg 40 drops 3 times a day.

If the condition worsens or does not improve within 3 days, consult a physician.
Do not use the drug without a prescription for more than 7 days.

Interaction

Guaifenesin enhances the analgesic effect of paracetamol and acetylsalicylic acid; enhances the sedative effect of alcohol, sedatives, hypnotics and general anesthetics on the central nervous system; enhances the effect of muscle relaxants.

Special Instructions

It is not recommended to drink alcoholic beverages during treatment with the drug.

Contraindications

Hypersensitivity to the ingredients, children under 6 months of age, first trimester of pregnancy, myasthenia gravis.

Side effects

If the recommended dosing regimen is followed, patients usually tolerate the drug well. Digestive disorders (nausea, lack of appetite, stomach pain, vomiting, diarrhea), headaches, dizziness and somnolence have been reported most frequently in about 1% of patients. These side effects usually decrease after dose reduction. Skin allergic reactions have also been observed.

Overdose

Symptoms: In overdose there are predominant signs of toxic effects of guaifenesin: drowsiness, muscle weakness, nausea and vomiting. The development of urolithiasis is possible.

Pregnancy use

Controlled clinical studies on the effects of the drug on pregnant women or animal studies have not been conducted.